Prescription Drug Procurement and the Federal Budget
This brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending.
View the Latest: Medicare Part D
Filter
-
-
Shifting the Cost of Dual Eligibles: Implications for States and the Federal Government
Issue BriefThis issue paper provides state-level estimates on spending on dual eligibles and illustrates the fiscal effects of scenarios where the federal government assumes the cost of prescription drugs, Medicare premiums, acute care, and long-term care for this population. Issue Paper (.
-
Hispanics and the New Medicare Drug Benefit
Poll FindingIn a few short weeks, Medicare will undergo big changes that will have a major impact on more than 3 million Hispanic seniors and younger people with permanent disabilities who rely on Medicare for their health coverage.
-
Toplines: National Survey of Pharmacists, Findings on Medicare Part D
Poll FindingThese toplines provide the results of a 2006 national survey of pharmacists on their views and experiences related to the new Medicare drug benefit. Topline (.
-
Kaiser Family Foundation/Harvard School of Public Health National Survey of the Public’s Views on Medicare
Poll FindingKaiser Family Foundation/Harvard School of Public Health National Survey of the Public's Views on Medicare A new national survey by the Kaiser Family Foundation and the Harvard School of Public Health examines the public's attitudes and opinions on issues related to the Medicare reform and prescription drug debate.
-
Key Facts About Medicare Drug Price Negotiation
Issue BriefUnder the Medicare Drug Price Negotiation Program, the federal government negotiates prices with drug companies for certain high-cost drugs covered under Medicare Part B and Part D. This brief provides information about several key aspects of the Medicare drug price negotiation program, with a focus on the 2028 implementation year.
-
States’ Concerns About the Medicare Drug Debate and the Fiscal Impact of Shifting the Cost of Dual Eligible Care
Issue BriefAs the U.S. Congress continues to search for an agreement on the form of a Medicare prescription drug benefit, the Commission has two new reports related to the debate.
-
NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care – Chart Pack
Poll FindingNew NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care A new survey by NPR, the Kaiser Family Foundation, and Harvard s Kennedy School of Government finds that many Americans have real problems when it comes to accessing and paying for health care, and even if they haven't yet faced a problem, many…
-
Prescription Drug Discount Cards: Current Programs and Issues
ReportAs policymakers consider a range of approaches to providing prescription drug coverage to the Medicare population in today s tight budgetary environment, one proposal that has been put forth by the Bush Administration is that of a Medicare-endorsed prescription drug discount card program.
-
The Role of PBMs in Managing Drug Costs: Implications for a Medicare Drug Benefit
Other PostExtending a drug benefit to Medicare beneficiaries has been a highly publicized issue in recent months.